Studies bladder sensation and overactive bladder in people with multiple sclerosis
Checks how bladder feelings during filling relate to overactive bladder in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
Key facts
- Where
- Paris, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT05772637, who can take part
Where in France
- Hôpital TenonParis, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT05772637
- Record updated
- 5 March 2026
- Original description
The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.Read full original descriptionShow less
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.
Inclusion: Age ≥ 18; MS according to the 2017 Mac Donald diagnostic criteria; Bladder disorders supposedly related to MS; Indication to perform urodynamics; No current medication for bladder disorders; Able to understand and right in French; Affiliated to the "Securite sociale" or "Couverture Medicale Universelle (CMU)", or equivalent organism.
Exclusion: Treatment with antimuscarinics, alpha blockers, beta3 adrenergic, or tibial nerve stimulation in the past 15 days, or with botulinic toxin injection in the past 6 months; Previous lower urinary tract surgery; Other associated neurological disease; Legal protection; Pregnancy or breastfeeding mother; MS relapse during the past month; Genuine stress incontinence related to postpartum; Inability to use the analogic device due to motor, sensory or ataxic disabilities.